Mechanisms of RNA-DNA repair
Mechanisms of RNA-DNA repair
批准号:
10336801
负责人:
Richard T Pomerantz
金额:
$36.53万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-08 至 2024-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Polymerase theta (Polq) is a unique polymerase-helicase fusion protein that performs multiple functions in DNA
repair in mammalian cells. Polq was initially characterized as a translesion DNA polymerase due to its ability to
perform replication opposite DNA lesions in vitro, and Polq translesion synthesis (TLS) has now been confirmed
in cells. Our laboratory and others have also identified an essential role for Polq in repairing double-strand breaks
(DSBs) via microhomology-mediated end-joining (MMEJ). Polq has also been implicated in replication repair,
base excision repair, somatic hypermutation and class-switch recombination. Whether this unique and error-
prone polymerase exhibits additional activities in DNA repair remains unknown.
Here, we discover that recombinant human Polq exhibits robust reverse transcriptase (RT) activity,
whereas all other human DNA polymerases tested from the A, B, Y and X families fail to perform reverse
transcription beyond 1-2 nucleotides. Polq generates identical reverse transcription products as retroviral RTs.
Unexpectedly, Polq exhibits a significantly higher velocity and fidelity of deoxyribonucleotide incorporation on
RNA versus DNA templates. These preliminary studies identify Polq as a novel RT in mammalian cells. We plan
to elucidate the molecular basis of Polq RT activity in vitro and investigate multiple RNA-templated DNA repair
(RNA-DNA repair) mechanisms in cells and in vivo by developing the following Aims: 1. To characterize Polq
reverse transcriptase activity in vitro; 2. To elucidate the molecular basis of Polq reverse transcriptase activity;
3. To investigate RNA-DNA repair using cellular and animal models. We anticipate that these studies will confirm
and characterize Polq RT activity in vitro and in a biological setting, and elucidate novel mechanisms of
mammalian RNA-DNA repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure Based Design of Pol-theta inhibitors
-
批准号:10323627
-
项目类别:
-
资助金额:$38.59万
-
财政年份:2021
-
负责人:Richard T Pomerantz
-
依托单位:
Next-generation precision medicine for targeting recombination-deficient cancers
-
批准号:9909705
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
PolQ as a novel therapeutic target in AML
-
批准号:10545175
-
项目类别:
-
资助金额:$52.39万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of RNA-DNA repair
-
批准号:10385826
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of RNA-DNA repair
-
批准号:10594960
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
PolQ as a novel therapeutic target in AML
-
批准号:10322361
-
项目类别:
-
资助金额:$53.58万
-
财政年份:2020
-
负责人:Richard T Pomerantz
-
依托单位:
Structure and Function of DNA Polymerase Theta
-
批准号:10094002
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2019
-
负责人:Richard T Pomerantz
-
依托单位:
Structure and Function of DNA Polymerase Theta
-
批准号:10377900
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2019
-
负责人:Richard T Pomerantz
-
依托单位:
Structure and Function of DNA Polymerase Theta
-
批准号:10336827
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2019
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9109640
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Targeting BRCA Deficient Cells for Killing
-
批准号:9114099
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9276915
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:8939152
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9309021
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:9751314
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms of Mammalian Double-Strand Break Repair
-
批准号:10322874
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2015
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8640444
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2013
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8824838
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2013
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8643774
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2013
-
负责人:Richard T Pomerantz
-
依托单位:
Mechanisms and Regulation of Human Translesion DNA Polymerases
-
批准号:8300404
-
项目类别:
-
资助金额:$12.27万
-
财政年份:2012
-
负责人:Richard T Pomerantz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
环状RNA介导DNA损伤-炎症通路调控NNK
诱导的肺癌发生
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:华秋翰
-
依托单位:
可编程的智能响应型“DNA纳米机器人”核酸自组装递释系统用于小激活RNA疗法和化疗协同抗肿瘤
-
批准号:2024Y9099
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈昌买
-
依托单位:
长非编码RNA P21-DIPOT在DNA损伤修复中的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王玉茗
-
依托单位:
诱导型ADAR1通过DNA-RNA杂合体堆积持续启动滞育样重编程介导舌鳞癌细胞休眠的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:李静远
-
依托单位:
基于 DNA 纳米折纸的Notch1小干扰 RNA 药
物的制备及其在肾癌靶向治疗中的作用与机
制研究
-
批准号:BZ24H180011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吴科荣
-
依托单位:
m7G修饰介导RNA选择性剪接调控DNA损伤修复促进膀胱癌顺铂耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:谢锐辉
-
依托单位:
基于DNA与RNA共检的肝癌精准诊疗系统开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:董辉
-
依托单位:
RNA m6A与DNA 5mC表观修饰crosstalk在牙鲆高温雄性化中的作用机制
-
批准号:42376094
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2023
-
负责人:王丽娟
-
依托单位:
AXIN通过增强天然免疫抵抗DNA和RNA病毒感染的功能及机制研究
-
批准号:82301985
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:戴丹玲
-
依托单位:
利用DNA酶10-23在早期胚胎中特异高效敲降RNA的研究和应用
-
批准号:82301878
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:范晓燕
-
依托单位: